BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 5 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $926,250 | -1.2% | 375,000 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $937,500 | -15.5% | 375,000 | -0.0% | 0.01% | -12.5% |
Q1 2023 | $1,110,000 | +43.7% | 375,001 | +0.0% | 0.02% | +23.1% |
Q4 2022 | $772,463 | -28.2% | 375,000 | 0.0% | 0.01% | -31.6% |
Q3 2022 | $1,076,000 | +10.4% | 375,000 | 0.0% | 0.02% | +11.8% |
Q2 2022 | $975,000 | -50.0% | 375,000 | 0.0% | 0.02% | -55.3% |
Q1 2022 | $1,950,000 | +10.9% | 375,000 | 0.0% | 0.04% | +31.0% |
Q4 2021 | $1,759,000 | -1.2% | 375,000 | 0.0% | 0.03% | -3.3% |
Q3 2021 | $1,781,000 | +163.9% | 375,000 | 0.0% | 0.03% | +150.0% |
Q2 2021 | $675,000 | +50.0% | 375,000 | -10.8% | 0.01% | +20.0% |
Q1 2021 | $450,000 | – | 420,536 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Privium Fund Management B.V. | 122,084 | $361,369 | 0.12% |
K.J. Harrison & Partners Inc | 170,750 | $505,420 | 0.10% |
Redmond Asset Management, LLC | 150,000 | $426,000 | 0.07% |
ARMISTICE CAPITAL, LLC | 375,001 | $1,110,000 | 0.02% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |